An E-platform for Learners

Day: November 5, 2025

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Semaglutide (Ozempic/Wegovy) Cuts Major Heart Risks Independent of Weight Loss, SELECT Trial Analysis Confirms

Pharm'Up

A recent research study conducted by University College London (UCL) has unveiled a groundbreaking finding from the...

Pfizer Sues Metsera and Novo Nordisk in Delaware, Alleging Breach of Merger Deal and Anticompetitive Conspiracy

Pfizer Sues Metsera and Novo Nordisk in Delaware, Alleging Breach of Merger Deal and Anticompetitive Conspiracy

Pharm'Up

Pfizer Inc. has escalated its battle with competitor Novo Nordisk A/S by filing a major lawsuit against...

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Groundbreaking Approval Kygevvi Receives FDA Nod as First Treatment for TK2 Deficiency (TK2d)

Pharm'Up

The U.S. Food and Drug Administration (FDA) has announced a landmark decision, approving Kygevvi (doxecitine and doxribtimine)...

USFDA Grants Tentative Approval to Zydus Lifesciences for Generic Crohn’s Disease Drug (Budesonide 4mg)

USFDA Grants Tentative Approval to Zydus Lifesciences for Generic Crohn’s Disease Drug (Budesonide 4mg)

Pharm'Up

Zydus Lifesciences Limited (Zydus) has achieved a significant regulatory milestone, securing tentative approval from the United States...